PETER MOLDT

Profile

First Name

: PETER

Middle Name

:

Last Name

: MOLDT

Related Companies
Titles
Company Name
Related People
DIRECTOR
CARDEAS PHARMA CORP
AARON DAVIDSON, ROBERT DEGAVRE, STEPHEN GRAHAM, KEVIN KINSELLA, A. BRUCE MONTGOMERY, ANTHONY SCULLION, MELISSA YEAGER
DIRECTOR
ALLAKOS INC.
ROBERT ALEXANDER, CHRISTOPHER BEBBINGTON, FARAH CHAMPSI, ALEJANDRO DORENBAUM, STEVE JAMES, DAN JANNEY, JOHN MCKEARN, NENAD TOMASEVIC, ADAM TOMASI, PAUL WALKER
DIRECTOR
BIOCLIN THERAPEUTICS, INC.
STEVE ABELLA, FOUAD AZZAM, THOMAS BOONE, GRAEME CURRIE, JULIE M. EASTLAND, ERIC EMERY, BRENT D. FASSETT, CORY FREEDLAND, JOCELYN HOLASH, JOEL JEAN-MAIRET, DAVID KABAKOFF, STEPHEN LAU, STEPHEN W. LAU, SCOTT D. MYERS, JACK NIELSEN, CHRISTIAN RICHARD, KENNETH SCHWARTZ, MARTEN STEEN, MARTIN STEEN, JOSEPH L. TURNER, ERIC YUEN
DIRECTOR
CORVUS PHARMACEUTICALS, INC.
ELISHA (TERRY) P. GOULD, TERRY G. GOULD, LEIV LEA, RICHARD A. MILLER, PETER THOMPSON
DIRECTOR
VASCULOX, INC.
KALTHLEEN L. BECKMANN, KATHLEEN L. BECKMANN, CHARLES BOLTEN, DAN BRODERICK, GEORGE CAPPS, JILL CARROLL, JOHN DONOVAN, WILLIAM FRAZIER, ROBERT W. KARR, PAMELA MANNING, PAMELA T. MANNING, JOHN MCKEARN, CAROLE L. NUECHTERLEIN, BOBBY W. SANDAGE, JR., JAMES STUTZ
DIRECTOR
E-SCAPE BIO, INC.
CARROLEE BARLOW, LAURA BRASS, LEON CHEN, GIOVANNI FERARRA, GIOVANNI FERRARA, MARKUS GOEBEL, PERRY KARSEN, JUDITH LI, ANTHONY RIMAC, ERIC SHIOZAKI, JULIE ANNE SMITH, PETER THOMPSON, R SANDERS WILLIAMS, R. SANDERS WILLIAMS, R. SANDERS WILLIAMS, PAUL WREN, ASISH XAVIER
DIRECTOR
TIOMA THERAPEUTICS, INC.
KALTHLEEN L. BECKMANN, KATHLEEN L. BECKMANN, CHARLES BOLTEN, DAN BRODERICK, GEORGE CAPPS, JILL CARROLL, JOHN DONOVAN, WILLIAM FRAZIER, ROBERT W. KARR, PAMELA MANNING, PAMELA T. MANNING, JOHN MCKEARN, CAROLE L. NUECHTERLEIN, BOBBY W. SANDAGE, JR., JAMES STUTZ
DIRECTOR
BOLT BIOTHERAPEUTICS, INC.
PETER BISGAARD, DAVID DORNAN, EDGAR ENGLEMAN, EDGAR G ENGLEMAN, EDGAR G. ENGLEMAN, KEN HARRISON, JAMES HEALY, ASHISH KHANNA, KATHLEEN LAPORTE, REINER LAUS, CHIH-PING LIU, RICHARD MILLER, EDITH PEREZ, WILLIAM QUINN, RANDALL SCHATZMAN, MAHENDRA SHAH, GRANT YONEHIRO
DIRECTOR
VIEWPOINT THERAPEUTICS, INC.
MARK BLUMENKRANZ, M.D., DOUGLAS CRAWFORD, EMMETT T. CUNNINGHAM, JR., JASON E. GESTWICKI, ED HURWITZ, HEATH LUKATCH, LEAH MAKLEY
DIRECTOR
OUTPOST MEDICINE, LLC
PETER BISGAARD, SCOTT BYRD, DANIEL ESTES, TERRY GOULD, DAVID A SOCKS, TADATAKA YAMADA, CHEN YU
DIRECTOR
SWIFT HEALTH SYSTEMS INC.
GLEN R. ANDERSON, ROBERT BARMANN, CLINT CARNELL, KENNY CHANG, KEVIN J COUSINS, VIJAY DHAKA, ANDREW GOLDBERG, RICHARD IVERSON, PHILONG PHAM, W. RONALD REDMOND, WILLIAM RONALD REDMOND, AARON ROYSTON, JOSEPH SILETTO, HONGSHENG TONG
DIRECTOR
ALIGOS THERAPEUTICS, INC.
HARDEAN ACHNECK, LEONID BEIGELMAN, LAWRENCE BLATT, LAWRENCE M. BLATT, LESLEY ANN CALHOUN, SUSHMITA CHANDA, MARGARITA CHAVEZ, BRIAN DOWD, JOHN FRY, KATHLEEN GLAUB, K. PETER HIRTH, PETER HIRTH, BRIDGET MARTELL, MATTHEW MCCLURE, CAROLE NEUCHTERLEIN, JACK NIELSEN, CAROLE NUECHTERLEIN, HEATHER PRESTON, LUCINDA QUAN, JAMES SCOPA, JULIAN SYMONS, TOM WOIWODE, MICHAEL YI
DIRECTOR
ESCAPE BIO, INC.
CARROLEE BARLOW, LAURA BRASS, LEON CHEN, GIOVANNI FERARRA, GIOVANNI FERRARA, MARKUS GOEBEL, PERRY KARSEN, JUDITH LI, ANTHONY RIMAC, ERIC SHIOZAKI, JULIE ANNE SMITH, PETER THOMPSON, R SANDERS WILLIAMS, R. SANDERS WILLIAMS, R. SANDERS WILLIAMS, PAUL WREN, ASISH XAVIER
DIRECTOR
AVALYN PHARMA INC.
TIBA AYNECHI, LYN BARANOWSKI, DANIEL D. BURGESS, JILL CARROLL, SOFIA IOANNIDOU, MICHAEL J. KAMDAR, JONATHAN LEFF, JONATHAN LEFF, M.D., CASSANDRA GIANNA LUCA, ROBERT MITTENDORFF, A. BRUCE MONTGOMERY, BRUCE MONTGOMERY, M.D., NIALL O-DONNELL, KETAN PATEL, HEATHER PRESTON, NAVEED SIDDIQI, MARK W. SURBER, PH.D., RICHARD G. VINCENT
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-10-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-22 
2021-09-09
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-27 
2021-06-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-06-01 
2020-09-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-14 
2020-01-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-23 
2019-07-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-16 
2019-07-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
2019-07-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-28 
2018-10-12
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-15 
2018-10-11
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-19 
2018-08-06
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-26 
2018-03-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-02 
2018-02-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-14 
2017-06-02
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-19 
2016-09-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-21 
2016-08-17
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-25 
2015-09-25
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-16 
2015-08-31
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-19 
2015-08-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-25 
2015-04-09
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-17 
2015-03-25
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-07 
2014-08-27
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-07 
2014-04-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2014-04-02 
2013-05-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-17 
2012-12-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-07 
2012-09-27
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-19 
2012-03-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-19 
2011-12-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-19